Notkun á mótlyfjum viðtaka GAL3 til þess að meðhöndla depru og/eða kvíða og efnasambönd sem eru nytsöm við aðferðirnar
This invention is directed to pyrimidine and indolone derivatives which are selective antagonists for the GAL3 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This in...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | ice |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | JOHN M. WETZEL HEIDI CHEN HERMO JIMENZ LAKMAN W. BOTEJU IAN JAMIE TALISMAN KITAE LIM BHARAT LAGU TOMAS P. BLACKBURN MICHEAL KONKEL STEWART NOBLE MATHIVANAN PACKIARAJAN |
| description | This invention is directed to pyrimidine and indolone derivatives which are selective antagonists for the GAL3 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject an amount of a compound of the invention effective to treat the subject's depression and/or anxiety. This invention also provides a method of treating depression and/or anxiety in a subject which comprises administering to the subject a composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a GAL3 receptor antagonist. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_IS6880A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>IS6880A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_IS6880A3</originalsourceid><addsrcrecordid>eNqFjD0KwkAQRtNYiHoDi7mAKAQkrYh_IDbah9HMxpjdTchuAjmAB_EAwoKQ0mYuZoL2Vg--7_H63v2Q2bTUwA9Q_LKyFrdSQZWws5gibBZ7H2wigd9kDCA7UMTuyo2OJEJEeVFCFk_bDSGt-Nkxi4GERoPq3HlgSAG1nq6t4eZb71KCCnZJobEYej2B0tDox4E3Xq9Oy-2E8iwkk-OFNNlwd5wHwWzh_7k_69dSVQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Notkun á mótlyfjum viðtaka GAL3 til þess að meðhöndla depru og/eða kvíða og efnasambönd sem eru nytsöm við aðferðirnar</title><source>esp@cenet</source><creator>JOHN M. WETZEL ; HEIDI CHEN ; HERMO JIMENZ ; LAKMAN W. BOTEJU ; IAN JAMIE TALISMAN ; KITAE LIM ; BHARAT LAGU ; TOMAS P. BLACKBURN ; MICHEAL KONKEL ; STEWART NOBLE ; MATHIVANAN PACKIARAJAN</creator><creatorcontrib>JOHN M. WETZEL ; HEIDI CHEN ; HERMO JIMENZ ; LAKMAN W. BOTEJU ; IAN JAMIE TALISMAN ; KITAE LIM ; BHARAT LAGU ; TOMAS P. BLACKBURN ; MICHEAL KONKEL ; STEWART NOBLE ; MATHIVANAN PACKIARAJAN</creatorcontrib><description>This invention is directed to pyrimidine and indolone derivatives which are selective antagonists for the GAL3 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject an amount of a compound of the invention effective to treat the subject's depression and/or anxiety. This invention also provides a method of treating depression and/or anxiety in a subject which comprises administering to the subject a composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a GAL3 receptor antagonist.</description><edition>7</edition><language>ice</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030721&DB=EPODOC&CC=IS&NR=6880A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030721&DB=EPODOC&CC=IS&NR=6880A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JOHN M. WETZEL</creatorcontrib><creatorcontrib>HEIDI CHEN</creatorcontrib><creatorcontrib>HERMO JIMENZ</creatorcontrib><creatorcontrib>LAKMAN W. BOTEJU</creatorcontrib><creatorcontrib>IAN JAMIE TALISMAN</creatorcontrib><creatorcontrib>KITAE LIM</creatorcontrib><creatorcontrib>BHARAT LAGU</creatorcontrib><creatorcontrib>TOMAS P. BLACKBURN</creatorcontrib><creatorcontrib>MICHEAL KONKEL</creatorcontrib><creatorcontrib>STEWART NOBLE</creatorcontrib><creatorcontrib>MATHIVANAN PACKIARAJAN</creatorcontrib><title>Notkun á mótlyfjum viðtaka GAL3 til þess að meðhöndla depru og/eða kvíða og efnasambönd sem eru nytsöm við aðferðirnar</title><description>This invention is directed to pyrimidine and indolone derivatives which are selective antagonists for the GAL3 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject an amount of a compound of the invention effective to treat the subject's depression and/or anxiety. This invention also provides a method of treating depression and/or anxiety in a subject which comprises administering to the subject a composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a GAL3 receptor antagonist.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFjD0KwkAQRtNYiHoDi7mAKAQkrYh_IDbah9HMxpjdTchuAjmAB_EAwoKQ0mYuZoL2Vg--7_H63v2Q2bTUwA9Q_LKyFrdSQZWws5gibBZ7H2wigd9kDCA7UMTuyo2OJEJEeVFCFk_bDSGt-Nkxi4GERoPq3HlgSAG1nq6t4eZb71KCCnZJobEYej2B0tDox4E3Xq9Oy-2E8iwkk-OFNNlwd5wHwWzh_7k_69dSVQ</recordid><startdate>20030721</startdate><enddate>20030721</enddate><creator>JOHN M. WETZEL</creator><creator>HEIDI CHEN</creator><creator>HERMO JIMENZ</creator><creator>LAKMAN W. BOTEJU</creator><creator>IAN JAMIE TALISMAN</creator><creator>KITAE LIM</creator><creator>BHARAT LAGU</creator><creator>TOMAS P. BLACKBURN</creator><creator>MICHEAL KONKEL</creator><creator>STEWART NOBLE</creator><creator>MATHIVANAN PACKIARAJAN</creator><scope>EVB</scope></search><sort><creationdate>20030721</creationdate><title>Notkun á mótlyfjum viðtaka GAL3 til þess að meðhöndla depru og/eða kvíða og efnasambönd sem eru nytsöm við aðferðirnar</title><author>JOHN M. WETZEL ; HEIDI CHEN ; HERMO JIMENZ ; LAKMAN W. BOTEJU ; IAN JAMIE TALISMAN ; KITAE LIM ; BHARAT LAGU ; TOMAS P. BLACKBURN ; MICHEAL KONKEL ; STEWART NOBLE ; MATHIVANAN PACKIARAJAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_IS6880A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ice</language><creationdate>2003</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>JOHN M. WETZEL</creatorcontrib><creatorcontrib>HEIDI CHEN</creatorcontrib><creatorcontrib>HERMO JIMENZ</creatorcontrib><creatorcontrib>LAKMAN W. BOTEJU</creatorcontrib><creatorcontrib>IAN JAMIE TALISMAN</creatorcontrib><creatorcontrib>KITAE LIM</creatorcontrib><creatorcontrib>BHARAT LAGU</creatorcontrib><creatorcontrib>TOMAS P. BLACKBURN</creatorcontrib><creatorcontrib>MICHEAL KONKEL</creatorcontrib><creatorcontrib>STEWART NOBLE</creatorcontrib><creatorcontrib>MATHIVANAN PACKIARAJAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JOHN M. WETZEL</au><au>HEIDI CHEN</au><au>HERMO JIMENZ</au><au>LAKMAN W. BOTEJU</au><au>IAN JAMIE TALISMAN</au><au>KITAE LIM</au><au>BHARAT LAGU</au><au>TOMAS P. BLACKBURN</au><au>MICHEAL KONKEL</au><au>STEWART NOBLE</au><au>MATHIVANAN PACKIARAJAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Notkun á mótlyfjum viðtaka GAL3 til þess að meðhöndla depru og/eða kvíða og efnasambönd sem eru nytsöm við aðferðirnar</title><date>2003-07-21</date><risdate>2003</risdate><abstract>This invention is directed to pyrimidine and indolone derivatives which are selective antagonists for the GAL3 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject an amount of a compound of the invention effective to treat the subject's depression and/or anxiety. This invention also provides a method of treating depression and/or anxiety in a subject which comprises administering to the subject a composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a GAL3 receptor antagonist.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | ice |
| recordid | cdi_epo_espacenet_IS6880A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Notkun á mótlyfjum viðtaka GAL3 til þess að meðhöndla depru og/eða kvíða og efnasambönd sem eru nytsöm við aðferðirnar |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T17%3A56%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JOHN%20M.%20WETZEL&rft.date=2003-07-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EIS6880A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |